ELATIVE Trademark
ELATIVE is a USPTO trademark filed by GENFIT. Status: Registered.
Trademark Facts
| Mark | ELATIVE |
|---|---|
| Serial Number | 79312182 |
| Registration Number | 6681657 |
| Status | Registered |
| Filing Date | 2021-01-20 |
| Registration Date | 2022-03-29 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals), 042 (Software & IT) |
| Owner | GENFIT |
| Attorney of Record | Brooks R. Bruneau |
| Prosecution Events | 29 |
| Latest Event | NREP on 2025-06-19 |
Goods & Services
Pharmaceutical preparations for the prevention and treatment of liver diseases, cholestatic diseases, metabolic diseases, cancer diseases, inflammatory diseases, autoimmune diseases and cancers; chemical preparations for medical or pharmaceutical use, namely for the prevention and treatment of liver diseases, cholestatic diseases, metabolic diseases, cancer diseases, inflammatory diseases, autoimmune diseases and cancers; organic preparations for medical or pharmaceutical use, namely for the prevention and treatment of liver diseases, cholestatic diseases, metabolic diseases, cancer diseases, inflammatory diseases, autoimmune diseases and cancers; diagnostic preparations for medical use; diagnostic reagents for medical use; Scientific research for medical purposes; pharmaceutical research and development services; conducting clinical trials for pharmaceutical products for others, in particular conducting clinical trials for determining the efficacy and safety of elafibranor; conducting clinical trials for others to determine the efficacy and safety of pharmaceutical products in the treatment of primary biliary cholangitis (PBC); conducting scientific studies and analyses in the field of pharmaceuticals and medicines; scientific research and development, namely, providing information, results and data relating to scientific or medical research and development of pharmaceutical products, via an online searchable database; conducting clinical trials for others; pharmaceutical and biological product development and research services for third parties; conducting clinical research for others; evaluation of the efficacy of pharmaceutical products; clinical product development services